NCT02632448 2025-05-02
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer
Esperas Pharma Inc.
Phase 1/2 Completed
Esperas Pharma Inc.
Wake Forest University Health Sciences
City of Hope Medical Center
King Faisal Specialist Hospital & Research Center
Northwestern University
Centro Nacional de Investigaciones Oncologicas CARLOS III